Thrombosis Research
Volume 125, Issue 3 , Pages 257-261 , March 2010

PAR1 antagonist mediated antithrombotic activity in extracorporeal arterio-venous shunt in the rat

Received 12 December 2008 ,Revised 4 May 2009 ,Accepted 5 May 2009.

References 

  1. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057–1068
  2. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev. 2004;84:579–621
  3. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 1999;103:879–887
  4. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407:258–264
  5. Kinlough-Rathbone RL, Rand ML, Packham MA. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets. Blood. 1993;82:103–106
  6. Derian CK, Santulli RJ, Tomko KA, Haertlein BJ, Andrande-Gordon P. Species differences in platelet responses to thrombin and SFLLRN receptor-mediated calcium mobilization and aggregation, and regulation by protein kinases. Thromb Res. 1995;78:505–519
  7. Hishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 1997;386:502–506
  8. Leger AJ, Jacques SL, Badar J, Kaneider NC, Derian CK, Andrade-Gordon P, et al. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis. Circulation. 2006;113:1244–1254
  9. Wu CC, Hwang TL, Liao CH, Kuo SC, Lee FY, Lee CY, et al. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3. Thromb Haemost. 2002;87:1026–1033
  10. Ahn HS, Foster C, Boykow G, Stamford A, Manna M, Graziano M. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol. 2000;60:1425–1434
  11. Ahn HS, Chackalamannil S. Nonpeptide thrombin receptor antagonists. Drugs Future. 2001;26:1065–1085
  12. Chackalamannil S, Xia Y. Thrombin receptor (PAR-1) antagonists as novel antithrombotic agents. Expert Opin Ther Patents. 2006;16:493–505
  13. Valentin JP, Vieu S, Bertolino F, Fauré P, John GW. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits. J Pharmacol Exp Ther. 1997;280:761–769
  14. Wollny T, Iacoviello L, Buczko W, de Gaetano G, Donati MB. Prolongation of bleeding time by acute hemolysis in rats: a role for nitric oxide. Am J Physiol. 1997;272:H2875–H2884
  15. Gill TJ, Smith GJ, Wissler RW, Kunz HW. The rat as an experimental animal. Science. 1989;245:269–276
  16. Smith LJ, Schaible KL, Fessler RG, Rachlin JR, Brown FD. Examination of the utility of the rat as an animal model for human anticoagulation. Haemostasis. 1987;17:206–210
  17. Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and haemostasis: basic principles and applications. ICTH-Report-Subcommittee on rheology of the international committee on thrombosis and haemostasis. Thromb Haemost. 1986;55:415–435
  18. Shand RA, Smith JR, Wallis RB. Expression of the platelet procoagulant activity in vivo in thrombus formation in an extracorporeal shunt in the rat. Thromb Res. 1984;36:223–232
  19. Colotta F, Sciacca FL, Sironi M, Luini W, Rabiet MJ, Mantovani A. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol. 1994;144:975–985
  20. Peng CY, Pan SL, Guh JH, Liu YN, Chang YL, Kuo SC, et al. The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury. Thromb Haemost. 2004;92:1232–1239

PII: S0049-3848(09)00219-9

doi: 10.1016/j.thromres.2009.05.004

Thrombosis Research
Volume 125, Issue 3 , Pages 257-261 , March 2010